Skip to main content
Year archive

Vita 34 AG — 2023 filings

All 43 regulatory filings released by Vita 34 AG (V3V) in 2023, sourced directly from the official regulator.

43 Filings
2023 Period
2023 filings (43)
Filing Released Lang
Vita 34 AG: AOC Health GmbH, Acquisition of shares as part of a capital increase
Director's Dealing
2023-12-11 English
Vita 34 AG: Jakub Julian Baran, buy
Director's Dealing
2023-12-11 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-12-07 English
Satzung
Governance Information
2023-11-28 German
Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors
Share Issue/Capital Change
2023-11-27 English
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
Earnings Release 9M 2023
2023-11-24 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report 9M 2023
2023-11-24 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report 9M 2023
2023-11-24 English
Report Publication Announcement 2023
Report Publication Announcement
2023-11-17 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.07.2023 bis zum 30.09.2023
Report Publication Announcement
2023-11-17 German
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.07.2023 bis zum 30.09.2023
Report Publication Announcement
2023-11-17 German
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements
Legal Proceedings Report
2023-11-10 English
Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor
Legal Proceedings Report
2023-09-27 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-09-05 German
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
Earnings Release H1 2023
2023-08-31 English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.06.2023
Interim / Quarterly Report H1 2023
2023-08-31 German
Half-yearly financial report 2023
Interim / Quarterly Report H1 2023
2023-08-31 English
Half-yearly financial report 2023
Interim / Quarterly Report H1 2023
2023-08-31 English
Report Publication Announcement 2023
Report Publication Announcement
2023-08-24 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement
2023-08-24 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement
2023-08-24 German
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
Earnings Release Q1 2023
2023-05-31 English
Q1 Mitteilung / Q1 Finanzbericht 2023
Interim / Quarterly Report Q1 2023
2023-05-31 German
Q1 statement / Q1 financial report 2023
Interim / Quarterly Report Q1 2023
2023-05-31 English
Report Publication Announcement 2023
Report Publication Announcement
2023-05-24 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2023 bis zum 31.03.2023
Report Publication Announcement
2023-05-24 German
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2023 bis zum 31.03.2023
Report Publication Announcement
2023-05-24 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report FY 2022
2023-05-19 German
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report FY 2022
2023-05-16 German
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
Environmental & Social Information
2023-05-12 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report FY 2022
2023-05-10 German
Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
Earnings Release FY 2022
2023-04-30 English
Annual financial report 2022
Annual Report FY 2022
2023-04-30 English
Declaration on Corporate Governance 2022
Governance Information
2023-04-28 English
Erklärung zur Unternehmensführung 2022
Governance Information
2023-04-28 German
Vita 34 AG publishes outlook for the 2023 financial year
Management Reports
2023-04-25 English
Report Publication Announcement 2023
Report Publication Announcement
2023-04-21 English
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-04-21 German
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-04-21 German
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-04-21 German
2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
Earnings Release FY 2022
2023-04-06 English
Declaration of Conformity 2023
Governance Information
2023-03-29 English
Entsprechenserklärung 2023
Governance Information
2023-03-29 German